Companies /Healthcare

Option Care Health Inc

NASDAQ: OPCH Medical Care Facilities
$31.65
▼ $0.03 (−0.09%) today
Markets closed · 4:57pm ET

24/7 Wall St. View

OPCH at a Glance

Valuation
Market cap
$4.7B
P/E ratio
22.9
Profitability
Revenue (TTM)
$5.8B
Profit margin
3.7%
EPS (TTM)
$1.38
Price
52-week range
$18 – $37
24/7 target
$36.14
Street target
$30.03
Earnings
Next report
Jan 11, 2027

Headquartered in Bannockburn, IL Fiscal year ends December NASDAQ: OPCH optioncarehealth.com

About Option Care Health

Option Care Health, Inc. (Nasdaq: OPCH) describes itself as the nation's largest independent provider of home and alternate site infusion services. It serves patients with acute and chronic conditions in all 50 states, with over 8,000 team members, including more than 5,000 clinicians. Its model centers on delivering infusion therapies outside the hospital, at patients' homes and at alternate sites such as infusion suites. Revenue comes largely from managed care organizations and other third-party payers, and the business depends on pharmaceuticals compatible with its infusion services. The company has entered into a definitive merger agreement under which it will be acquired by Clayton, Dubilier & Rice, LLC and McKesson Corporation. Completion depends on stockholder and regulatory approvals and other closing conditions. Updated

Latest Activity

OPCHOption Care Health
Q3 2026
EPS
$0.49
est $0.49+0.6%
Revenue
$1.49B
est $1.48B+1.2%

Option Care Health beat on both lines and then went silent: no earnings call and all prior guidance withdrawn while the Clayton, Dubilier & Rice and McKesson buyout is pending. Adjusted EBITDA rose 4.3% to $124.6 million, so the operating story stays intact, but the numbers are all investors get until the deal closes.

Quarterly EPS — reported vs estimate

OPCH Coverage

Frequently Asked Questions

What does Option Care Health do?

Option Care Health, Inc. (Nasdaq: OPCH) describes itself as the nation's largest independent provider of home and alternate site infusion services. It serves patients with acute and chronic conditions in all 50 states, with over 8,000 team members, including more than 5,000 clinicians.

What is the OPCH stock price target?

24/7 Wall St.'s 12-month price target for OPCH is $36.14, rated Buy. The Wall Street consensus target is $30.03. OPCH price prediction →